Wipfli Corporate Finance Advisors, LLC has announced that Argano, LLC, a portfolio company of Trinity Hunt Partners, has acquired Pharosity Consulting Inc.
Founded in 2015 by Mike McCarthy, Rob Ririe and Brian Barbash, Pharosity is a specialized life sciences consulting firm with deep expertise in gross-to-net, government pricing, commercial contracting and advanced analytics for pharmaceutical and biotechnology companies. Argano is a leading digital services consultancy focused exclusively on enabling high performance across its clients’ business operations, at scale and around the globe.
The acquisition of Pharosity deepens Argano’s life sciences capabilities and is the latest step in Argano’s ongoing effort to expand its domain-specific expertise and AI-enabled transformation services. The transaction creates significant cross-sell opportunities with Argano’s enterprise technology, data integration and performance consulting services, positioning the firm for continued growth in the pharmaceutical and biotechnology sectors. Pharosity’s leadership has built a reputation for delivering structured operating models that support complex regulatory and commercial functions with consistency and speed.
“Joining Argano enables us to extend our reach while continuing to deliver the focused expertise our clients value,” said Brian Barbash, cofounder of Pharosity. “We are excited to scale within a platform that prioritizes precision, partnership and sustainable outcomes, expanding what we can provide to our pharmaceutical clients as they navigate complexities and drive better results.”
The acquisition marks Argano’s eighth addition since the inception of its transformational growth program announced in April 2025, and the twenty-fourth since the company’s founding in 2020.
“As we move into 2026, Argano continues to build momentum through a disciplined acquisition strategy that is expanding both our scale and industry depth,” said Chip Register, Group CEO of Argano. “Pharosity’s distinct specialization and proven team complement our platform well, and we’re excited to welcome them to Argano. This acquisition supports our continued focus on delivering AI-enabled high-performance operations for pharmaceutical organizations facing increasingly complex regulatory and data environments.”
The transaction closed in December 2025. Details of the sale are confidential. Wipfli Corporate Finance acted as exclusive financial advisor to Pharosity Consulting in connection with the investment. Messerli Kramer served as legal counsel.
Investment banking services provided by RKCA, Inc., Member SIPC/FINRA, 1077 Celestial Street, Cincinnati, Ohio 45202. Phone: 513.371.5533. Certain Wipfli Corporate Finance Advisors, LLC associates are registered representatives of RKCA, Inc. Wipfli Corporate Finance Advisors, LLC is a subsidiary of Wipfli LLP. Certain accounting, tax, business advisory, and other services are provided by Wipfli LLP. RKCA, Inc. does not provide accounting, tax or legal advice. Investing involves the risk of loss. Past performance is not indicative of future results.
The persons providing the testimonials herein have experience in the services that were provided by RKCA/WCF. Their respective experience with RKCA/WCF may not be representative of all other Clients of RKCA. Testimonials are not paid for by RKCA/WCF. Testimonials do not constitute a guarantee of future performance or success related to any product, transaction or service.
This information should not be construed as a recommendation, offer to sell, or solicitation of an offer to buy a particular security or investment strategy. The commentary provided is for informational purposes only and should not be relied on for accounting, legal, or tax advice. Though the information is deemed reliable, Wipfli Corporate Finance Advisors, LLC cannot guarantee its accuracy, completeness, or suitability for any purpose and makes no warranties with regard to the results to be obtained from its use. Past performance does not guarantee future results.